Evolution of the National Academy of Sciences study of naltrexone.
D000047:Academies and Institutes; D002986:Clinical Trials as Topic; D003496:Cyclazocine / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D006556:Heroin Dependence / Q000534:rehabilitation; D006801:Humans; D008297:Male; D009270:Naloxone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009271:Naltrexone / Q000009:adverse effects / Q000627:therapeutic use*; D012107:Research Design; D012109:Research Support as Topic
D009270:Naloxone; D009271:Naltrexone; D003496:Cyclazocine